title: What's new in the treatment of neonatal shock.
abstract: Shock is a clinical disorder that challenges caregivers in the neonatal intensive care unit. The predominant cause of shock in neonates is sepsis. This article provides an overview of the current treatment of septic shock with particular emphasis on newer vasoactive drugs (milrinone, levosimendan and vasopressin) to support cardiovascular dysfunction.
authors: Pediatric Emergency and Intensive Care, Department of Pediatrics, Sapienza University of Rome, Rome, Italy. elencare@yahoo.it
authors: Elena
authors: E
authors: Caresta
authors: Paola
authors: P
authors: Papoff
authors: Sara
authors: S
authors: Benedetti Valentini
authors: Michele
authors: M
authors: Mancuso
authors: Roberto
authors: R
authors: Cicchetti
authors: Fabio
authors: F
authors: Midulla
authors: Corrado
authors: C
authors: Moretti
mesh_terms: D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000628:therapy; D007363:Intensive Care Units, Neonatal / Q000639:trends*; D009359:Neonatology / Q000379:methods / Q000639:trends*; D012769:Shock / Q000151:congenital / Q000175:diagnosis / Q000628:therapy; D012772:Shock, Septic / Q000151:congenital* / Q000175:diagnosis / Q000628:therapy*